Seems like we would not be too far from this sort of deal. We could certainly use 15MM right now to hire some more techs and move things along faster. I wonder what ArQule had to give to Roche in exchange? Also, how does this approach differ from ssDNA?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.